ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Management of acne keloidalis nuchae

Management of acne keloidalis nuchae
Secondary infection may complicate acne keloidalis nuchae. Findings suggestive of infection (extensive erythema, suppuration, pain, drainage, odor, or systemic symptoms) should prompt assessment and/or treatment for infection.
* The following clinical findings can be used to determine severity:
  • Mild to moderate inflammation – Nonconfluent, small, inflammatory papules or pustules in the involved area.
  • Moderate to severe inflammation – Numerous inflammatory lesions; extensive pustulation or suppuration; or large, inflammatory lesions.
¶ Topical corticosteroid therapy is often combined with topical antibacterial therapy and/or topical retinoid therapy in an attempt to augment the response to treatment. In our experience, inclusion of a topical antibacterial agent can be particularly helpful in patients with pustules. Examples of topical antimicrobials include clindamycin-benzoyl peroxide combination gel, erythromycin-benzoyl peroxide combination gel, benzoyl peroxide, and erythromycin.
Δ Re-evaluate every 4 to 6 weeks to assess for improvement and adverse effects of topical corticosteroids. Responses are usually evident within 6 to 8 weeks for topical corticosteroids, within 4 to 6 weeks for topical antimicrobial agents, and within 8 to 12 weeks for topical retinoids.
Graphic 131607 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟